22 - CLAP

1067. Heath PT, Nik Yusoff NK, Baker CJ. Neonatal meningitis. Arch Dis Child Fetal Neonatal Ed. 2003May;88(3):F173-8.1068. Huang SH, Stins MF, Kim KS. Bacterial penetration across the blood-brain barrier during the developmentof neonatal meningitis. Microbes Infect. 2000 Aug;2(10):1237-44.1069. Klinger G, Chin CN, Beyene J, Perlman M. Predicting the outcome of neonatal bacterial meningitis.Pediatrics. 2000 Sep;106(3):477-82.1070. Manzar S. Neonatal Salmonella meningitis. Saudi Med J. 2000 Oct;21(10):989.1071. Matthew L, Chandran U. Neonatal salmonella meningitis. Saudi Med J. 2000 May;21(5):498-9.1072. Miller V. Neonatal cerebral infarction. Semin Pediatr Neurol. 2000 Dec;7(4):278-88.1073. Nagai K, Sakata Y. Risk factors for clinical prognosis in bacterial meningitis beyond the neonatal periodKansenshogaku Zasshi. 1998 Aug;72(8):781-7.1074. Nel E. Neonatal meningitis: mortality, cerebrospinal fluid, and microbiological findings. J Trop Pediatr.2000 Aug;46(4):237-9.1075. Polin RA, Harris MC. Neonatal bacterial meningitis. Semin Neonatol. 2001 Apr;6(2):157-72.1076. Pong A, Bradley JS. Bacterial meningitis and the newborn infant. Infect Dis Clin North Am. 1999Sep;13(3):711-33, viii.1077. Stevens JP, Eames M, Kent A, Halket S, Holt D, Harvey D. Long term outcome of neonatal meningitis.Arch Dis Child Fetal Neonatal Ed. 2003 May;88(3):F179-84.1078. Wojsyk-Banaszak I, Szczapa J. Central nervous system infections in neonates caused by multiresistantKlebsiella pneumoniae Ginekol Pol. 2000 Sep;71(9):975-8.Enfermedad de membrane hyalina1079. Agrons GA, Harty MP. Lung disease in premature neonates: impact of new treatments and technologies.Semin Roentgenol. 1998 Apr;33(2):101-16.1080. Ambrosius-Diener K. Hypoxia, an important pathogenetic factor in hyaline membrane disease in thenewborn infant Bol Med Hosp Infant Mex. 1984 Mar;41(3):140-6.1081. Cerezo R. Problemas respiratorios en el neonato. En Medicina Neonatal 2ª Ed. Cerezo R, Figueroa REds. Librerías Paris, Guatemala 1994. pp 269-3481082. Dawson KA, DeVos D. Hyaline membrane disease. Radiol Technol. 1996 Mar-Apr;67(4):341-2.1083. Goraya JS, Nada R, Ray M. Hyaline membrane disease in a term neonate. Indian J Pediatr. 2001Aug;68(8):771-3.1084. Kennedy JD. Lung function outcome in children of premature birth. J Paediatr Child Health. 1999Dec;35(6):516-21.1085. Kumar A, Bhat BV. Epidemiology of respiratory distress of newborns. Indian J Pediatr. 1996 Jan-Feb;63(1):93-8.1086. Lauweryns JM, Bourgeois N. Pulmonary ultrastructure in neonatal hyaline membrane disease. Arch DisChild. 1970 Feb;45(239):146.1087. Lewins MJ, Whitfield JM, Chance GW. Neonatal respiratory distress: potential for prevention. Can MedAssoc J. 1979 May 5;120(9):1076-80.1088. Loe Sioe Thoen, Soeparto P, Djojopranoto M, Darsono I. Hyaline membrane disease of the lungs. PaediatrIndones. 1968 May-Jun;8(3):123-8.1089. Magny JF, RigourdV, Kieffer F,Voyer M. Perinatal corticosteroid therapy: modalities, efficacy,consequencesJ Gynecol Obstet Biol Reprod (Paris). 2001 Feb;30 Suppl 1:36-46.1090. Mazzi E, Rivera L, Camberos O. Síndrome de dificultad respiratoria por deficiencia de surfactante.Maduración pulmonar y administración de surfactante. En Perinatología 2a Ed. Mazzi E, Sandoval O.Eds. Bolivia, 2002.pp 407-4251091. McAdams AJ, Bove KE. Hyaline membrane disease. Pediatr Pathol Lab Med. 1995 Jul-Aug;15(4):639-40.1092. Merenstein GB, Gardner SL. Handbook of neonatal intensive care. 2d Ed. CV Mosby Co. 1989MANUAL CLÍNICO AIEPI NEONATAL 154